Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
320 WEST 37TH STREET, NEW YORK, NY
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
4 Sep 2026

Immunovant, Inc. reported Shareholder voting results

Immunovant, Inc. filed an 8-K covering shareholder voting results.

14 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Immunovant, Inc..

6 Aug 2026

Immunovant, Inc. filed Form 10-Q

Immunovant, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

6 Aug 2026

Immunovant, Inc. reported Operating or financial results

Immunovant, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

23 Jul 2026

Immunovant, Inc. proxy and shareholder-vote filing

Immunovant, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$797.80M
Total assets (USD)$852.49M
Total liabilities (USD)$117.10M
Shareholders' equity (USD)$735.39M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
Verified Financial Statements Unavailable
Verified financial statement data is not ingested for this stock yet.

Analyst Consensus

Buy
Target: $48.80
68.2% upside potential
📈
Strong Buy
Unavailable
👍
Buy
8
⏸️
Hold
2
📉
Sell
0
10 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 37.00–66.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
7
Oct 2026
Stout Jay S
Chief Technology Officer
Open-market sale
$32.06 per share
3,809 shares
SEC Form 4
7
Oct 2026
Van Tuyl Christopher
Chief Legal Officer
Open-market sale
$32.06 per share
1,327 shares
SEC Form 4
7
Oct 2026
Gloria Melanie
Chief Operating Officer
Open-market sale
$32.06 per share
2,241 shares
SEC Form 4
2
Oct 2026
Venker Eric
Director, Chief Executive Officer
Open-market sale
$34.11 per share
3,506 shares
SEC Form 4
1
Oct 2026
Venker Eric
Director, Chief Executive Officer
Option exercise
$14.46 per share
92,187 shares
SEC Form 4
1
Oct 2026
Venker Eric
Director, Chief Executive Officer
Disposition to the company
$33.65 per share
85,886 shares
SEC Form 4
23
Sep 2026
Van Tuyl Christopher
Chief Legal Officer
Open-market sale
$36.36 per share
2,846 shares
SEC Form 4
28
Aug 2026
Pande Atul
Director
Option exercise
$8.43 per share
1,500 shares
SEC Form 4
28
Aug 2026
Pande Atul
Director
Open-market sale
$43.27 per share
1,500 shares
SEC Form 4
20
Aug 2026
Gloria Melanie
Chief Operating Officer
Open-market sale
$44.16 per share
3,056 shares
SEC Form 4

Top Shareholders

Fmr Llc
16,186,469 shares
-4.493% change
6/30/2026
Deep Track Capital, Lp
9,341,151 shares
-18.963% change
6/30/2026
Vanguard Group Inc
7,779,314 shares
13.952% change
12/31/2025
Blackrock, Inc.
7,180,897 shares
9.224% change
6/30/2026
Farallon Capital Management, L.L.C.
5,805,000 shares
275.485% change
6/30/2026
Baker Bros. Advisors Lp
5,435,220 shares
-0.415% change
6/30/2026
State Street Corp
4,617,005 shares
1.743% change
6/30/2026
Two Seas Capital Lp
4,612,692 shares
46.504% change
9/30/2026
Morgan Stanley
4,534,833 shares
16.971% change
6/30/2026
Tcg Crossover Management, Llc
4,457,988 shares
0% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 16 hours ago